More results...
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Backgrounder
Biosimilars Bulletin
Blog
Council Resource
Event
Handbook
Infographic
Interchangeability
Issue Brief
Media
Member Spotlight
Partner Resource
Policy Recommendation
Press Release
Report
Statement
Streamlining
Video
Whitepapers
LinkedIn
Twitter
Facebook
YouTube
Take Action
About
Interchangeability
Advocacy
Events
Resources
All Resources
Biosimilars Bulletin
Biosimilars Handbook
Biosimilars Timeline
Patient Resource Center
Reports & White Papers
Research & Studies
Streamlining
Blog
News
Press Releases
FDA-Approved Biosimilars
In the News
Home
/
In the News
Biosimilars Council Applauds Senate Passage of Cornyn-Blumenthal Patent Thicket Legislation
July 12, 2024
Biosimilars Council Submits Comments to FDA for Promotional Labeling and Advertising Considerations
June 26, 2024
Biosimilars Council Applauds Updated FDA Guidance on Interchangeability
June 21, 2024
Biosimilars Council Calls for More Efficient Regulatory Pathways for Critical Medicines
May 30, 2024
PBM Rebate Schemes to Suppress Biosimilar Humira Cost U.S. Patients $6 Billion
April 2, 2024
Kentucky Is The Latest State To Enact Legislation To Increase Patient Access To Lower-Cost Biosimilar Medicines
March 18, 2024
Load more
Filter by Keyword
Filter by Audience
Filter by Category
Filter by Keyword
Filter by Issue
Filter by Category
MENU
About
Interchangeability
Advocacy
Events
Resources
All Resources
Biosimilars Bulletin
Biosimilars Handbook
Biosimilars Timeline
Patient Resource Center
Reports & White Papers
Research & Studies
Streamlining
Blog
News
Press Releases
FDA-Approved Biosimilars